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Abstract
Accurate tracing of cell viability is critical for optimizing delivery methods, and evaluating the 
efficacy and safety of cell therapeutics. A nanoparticle-based cell tracker is developed to image 
cell fate from live to dead. The particle is fabricated from two types of optically quenched 
polyelectrolytes, a life indicator and a death indicator, through electrostatic interactions. Upon 
incubation with cells, the fabricated bifunctional nanoprobes are taken up efficiently, and the first 
color is produced by normal intracellular proteolysis, reflecting the healthy status of the cells. 
Depending on the number of coated layers, the signal can persist for several replication cycles. 
However, as the cells begin dying, the second color appears quickly to reflect the new cell status. 
Using this chameleon-like cell tracker, live cells can be distinguished from apoptotic and necrotic 
cells instantly and definitively.
Cell therapies, including stem cell therapy, have been considered as alternative approaches 
for various regenerative diseases; however, initial studies have been disappointing, partially 
because the distribution and function of the injected cells were unable to be assessed in real 
time1. This limitation made optimization difficult and indirectly contributed to poor 
therapeutic outcomes. Over the past few decades, imaging technologies and downstream 
applications have dramatically advanced. Visualizing or tracking biological processes for 
diagnostic and therapeutic purposes provides critical information in guiding medical 
research and clinical operations2. Similarly, advanced imaging technology that is capable of 
tracking therapeutic cells could aid the development of cell therapies. Thus far, only a few 
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non-invasive imaging technologies have been developed to monitor distribution, 
functionality, and viability of injected cells3, 4, 5.
To study injected cells, transgenic reporters, such as green fluorescent protein (GFP), 
luciferase, and thymidine kinase, have been widely used in animals6, 7. However, 
introducing a foreign gene into therapeutic cells always causes safety concerns, such as the 
potential risk of immunogenicity and tumorigenicity induced by random integration of 
reporter genes8, 9. Compared to a simple chemical labeling approach, transfection 
procedures are also time-consuming. Thus, various synthetic materials have been used as 
imaging reagents including organic dyes, polymers, and inorganic nanoparticles10, 11, 12. 
Although inorganic nanoparticles, such as quantum dots (QDs), are highly luminescent and 
resistant to photobleaching, their usage for cell labeling is limited due to their potential 
cytotoxicity and unstable fluorescence signals, especially in dividing cells13, 14. 
Alternatively, fluorescent dyes were developed in parallel to track cells in real-time in 
vivo15, 16.
In addition to tracking the distribution of the injected cells, their viability is another critical 
factor for cell therapy. Methods for non-invasive imaging of cell death (i.e. apoptosis and 
necrosis) have been developed to report cell states and their responses to therapeutic 
interventions17, 18. Both intracellular biomarkers, such as caspases19, 20 and mitochondrial 
membrane potential21, and extracellular biomarkers, such as plasma membrane 
phosphatidylserine (PS)22, 23, 24, phosphatidylethanolamine (PE)25, and cell surface exposed 
histone26, are regularly used to indicate apoptosis. For necrosis, the most accepted 
biomarker is DNA that becomes accessible after disruption of the cell plasma membrane27. 
DNA binding agents, such as Hoechst28 and hypericin29, are used to label extracellular DNA 
released from necrotic cells.
Although the aforementioned protocols provide valuable information about injected cells, 
they can only report the current status of the cells when the labeling agent was applied. They 
are unable to reflect the status of cells over long periods of time. A multifunctional cell 
tracker, capable of reporting cell fate from live to dead in real-time, would be extremely 
valuable for optimizing cell therapy. Recently, we developed a long-lasting cell tracker 
containing a fluorescence signal that is able to last more than three weeks without noticeable 
cell toxicity30. Based on this live cell-imaging platform, a novel ingredient was included as a 
cell death reporter. The cell of interest could be conveniently labeled by simply mixing with 
the synthesized nanoprobe in vitro. The initial intracellular fluorescent color is stable in 
healthy cells for long periods of time. Should the cells turn apoptotic or necrotic, the 
nanoprobe will send a new fluorescence signal, which can be identified clearly by 
monitoring a second wavelength.
Results
Live cell tracker (L3)
The previously developed long-lasting probes were assembled by layering fluorochrome 
decorated poly-L-lysine (PLL) and poly(acrylic acid) (PAA) on an inert gold nanoparticle 
(AuNP) core, using a layer-by-layer (LbL) deposition technique30, 31. In living cells, PLL is 
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degraded naturally by several intracellular proteases such as cathepsin B and cathepsin 
L32, 33. Since the number of fluorochromes per PLL molecule was optimized for the 
maximum quenching of fluorescence at initial state and maximum recovery of fluorescence 
when it was degraded proteolytically in cells, a high signal to background ratio was observed 
while using this system. It was also confirmed that the nanoprobes, made of protease-
resistant poly-D-lysine (PDL) are not activated in cells30, thus no fluorescence signal could 
be detected in healthy cells, even after several days of incubation. However, during the 
studies, a few highly fluorescent round cells that were presumed dead were noticed 
occasionally. It was suspected that those bright fluorescence signals were generated by PDL 
degradation in the course of cell death. Based on this interesting observation, we thought 
that the PDL-containing nanoprobe could be useful in imaging cell death. To prove this 
hypothesis, PLL with cyanine dye (cy) 5.5 and PDL with fluorescein isothiocyanate (FITC) 
were prepared for live cell and dead cell imaging, respectively.
The optimal loading ratio of cy5.5 per PLL molecule was assessed using a series of cy5.5 
concentrations, and their protease accessibility was determined using trypsin as a model 
protease. Cy5.5/PLL ratios were from 1/1 to 7/1, and the optimal ratio was found to be 7/1 
(termed PLL-C7) among all preparations. This ratio provided the maximum dequenching 
value upon protease treatment (>9-fold) (Supplementary Fig. 1). The activation of PLL-C6 
(6/1 ratio of Cy5.5/PLL) was slightly lower than that of PLL-C7. Nanoprobes, NP-(PLL-
Cn)3, were then fabricated with 3 layers of PLL-Cn polymers using the previously 
developed protocol and subjected to protease activation (Supplementary Fig. 2a). All of the 
fabricated nanoprobes were stable in phosphate buffered saline (PBS), but when treated with 
trypsin, the fluorescence signal increased significantly (Supplementary Fig. 2b). The optimal 
formulations were the ones assembled with PLL-C6 (NP-(PLL-C6)3) and PLL-C7 (NP-
(PLL-C7)3), whose fluorescence increased by greater than 250-fold after 24 h of incubation. 
PLL-C6 was then selected to prepare nanoprobes with 3 layers of PLL-C6 (termed L3) for 
subsequent studies.
Dead cell tracker (D3)
Conversely, PDL was labeled with the same number of FITC molecules (FITC/PDL = 6/1), 
and the nanoprobes were fabricated by coating them with 3 layers of PDL-FITC (termed D3) 
using the same protocol. When the formulated nanoprobes were exposed to trypsin in tubes, 
as expected, fluorescence change was not detected in D3, but it increased quickly in L3, 
supporting the hypothesis that normal proteolysis cannot cleave unnatural PDL 
(Supplementary Fig. 3).
To validate the hypothesis that PDL would be cleaved in dying cells, D3 nanoprobes (Fig. 
1a) were investigated in both healthy and apoptotic cells. Healthy MDA-MB231 cells were 
incubated with D3 and then washed with complete culture medium. A commercially 
available apoptotic cell-labeling reagent, Annexin V-cy3, was added to detect apoptotic cells. 
No fluorescence signal could be observed in the Annexin V-cy3 channel or the D3 
fluorescein channel, confirming that all cells were healthy over the period of incubation and 
that D3 loading did not induce apoptosis (Fig. 1b). When the cells were treated with an 
apoptosis inducer, staurosporine (SSP), for 4 h, the FITC fluorescence signal of D3 was 
Lee et al. Page 3
Nat Commun. Author manuscript; available in PMC 2016 May 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
found co-existing with the Annexin-cy3 apoptosis signal (Fig. 1c). The FITC fluorescence 
intensity of cell lysates of the SSP treated cells was 3-fold higher than that of the cells 
without SSP, or the unlabeled cells (Fig. 1d). Similar results were also found in HeLa cells. 
To confirm that PDL degradation is a possible mechanism of fluorescence increase in D3 
treated cells, cell lysates were collected and ran through a size exclusion column. The 
fluorescence of each collected fraction was measured. High fluorescence was observed in 
the low molecular weight fractions, thereby suggesting that PDL was degraded during 
apoptosis (Fig. 1e). These data support the hypothesis that D3 activation is apoptosis 
dependent.
Cell fate tracker from live to dead (DL2)
Based on these observations, the original nanoparticle was re-designed to carry two 
reporters, one for the healthy stage and a second for the dying stage. AuNPs were first 
coated with PDL-FITC (D), spaced by a layer of counter ion polymer PAA (DA), and then 
followed by PLL-C6 (DL), PAA (DLA) and PLL-C6 (DL2). The assembled DL2 particle has 
one inner layer of PDL-FITC and two layers of PLL-C6, separated by two layers of PAA 
using electrostatic interactions (Fig. 2a). The hydrodynamic diameter of the prepared 
nanoprobes was measured by dynamic light scattering (DLS) after coating with each layer. 
The size of the initial bare AuNPs was 40 nm and the prepared particle size increased 
steadily with the number of layers (D: 54 nm; DL: 87 nm; DL2: 113 nm; Fig. 2b). The 
alternating layers of charged polyelectrolytes were evidenced by the zigzag pattern of the 
surface zeta potentials (Fig. 2b). The PLL and PDL layers converted the surface charge from 
negative to positive; whereas, the PAA layers converted the surface charge from positive to 
negative.
To demonstrate the usage of this all-in-one probe, MDA-MB231 cells were labeled with 
DL2. After the excess particles were washed away, the cells were cultured in normal culture 
medium and monitored under a fluorescence microscope daily. As previously observed, the 
PLL layers of the internalized DL2 were activated by normal intracellular proteolysis and 
produced a stable and long-lasting cy5.5 signal. During a 4-day incubation, no fluorescein 
signal, indicating apoptosis, was detected (Fig. 3a). When the apoptosis inducer SSP was 
added to the culture medium on day 4, cell death was incurred and, in consequence, green 
fluorescein signal was generated (Fig. 3b). These data strongly suggest that DL2 is suitable 
for long-term cell labeling and does not produce false apoptotic signals because, under 
normal conditions, healthy cells do not hydrolyze or activate the PDL molecule. Once 
apoptosis occurred, the PDL layer was degraded and the death signal was activated. A 
positive apoptosis control using a D3 nanoprobe gave only a FITC signal, but no cy5.5 
signals in cells (Fig. 3b).
It is known that, apoptosis is not the sole pathway causing cell death; necrosis also occurs 
under many conditions. To evaluate the potential usage of a PDL-containing nanoprobe in 
necrosis imaging, MDA-MB231 cells were incubated with DL2 and then treated with a 
widely used necrosis inducer, ionomycin (ION)34. As seen in Figure 3c and 3d, the necrotic 
cells fluoresced after induction, suggesting that PDL was also degraded during necrosis.
Lee et al. Page 4
Nat Commun. Author manuscript; available in PMC 2016 May 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Human mesenchymal stem cells (hMSCs) tracking
To test the feasibility of the nanoprobe in tracking therapeutic cells in vitro and in vivo, 
hMSCs were first incubated with DL2 and imaged before and after apoptosis induction. As 
previously observed in MDA-MB231 cancer cells, only the life signal of cy5.5 were 
generated in all hMSCs over a 4 days period. No FITC death signal was detected in hMSCs 
(Fig. 4a), until the apoptosis inducer SSP was added to the medium (Fig. 4b). Following the 
in vitro confirming imaging result, DL2 was tested in tracking hMSCs in vivo. DL2 labeled 
hMSCs were injected directly into the mouse ear pinna, and then the mice were imaged 
using a home-built confocal microscopy35. In 2 h, the majority of the cells maintained their 
viability by cy5.5 expression (Fig. 4c). However, a small portion of the injected cells showed 
evidence of cell death by labeling with FITC in addition to cy5.5. These results support the 
potential of DL2 to label live and dead stem cell populations in vivo.
A cytotoxicity assay of the prepared nanoprobes showed no significant cytotoxicity in 
MDA-MB231, HeLa or hMSCs after treatment with various nanoprobes for 24 h 
(Supplementary Fig. 4).
Death signal and reactive oxygen species (ROS)
The cultured results indicated that PDL is stable in healthy cells for long periods of time, but 
broken down quickly during apoptosis or necrosis. It is known that proteases recognize L-
form amino acid residues and degrade L-peptides with efficiency. In contrast, D-form amino 
acid residues cannot be recognized by most proteases; thus, D-amino acid capped peptides 
or formed peptides have been proposed to prolong the blood half-life of peptide drugs or 
peptide-based delivery systems36. There is little literature report about the biodegradation of 
D-peptides, besides an early report of PDL hydrolysis by pancreatic enzyme extracts37. A 
better understanding of the possible mechanism for PDL degradation is tempting.
Among the common factors that participate in cell death, ROS play critical roles in inducing 
apoptosis and necrosis38, 39, 40, 41. In addition, mounting evidence supports that SSP 
increases ROS production and induces cell death by promoting the intrinsic apoptotic 
pathway42, 43, 44, 45. Since cellular oxidative stress results from the increased ROS, and thus 
is directly linked to the induction of cell death46, it is thus suspected that ROS could 
contribute to PDL degradation. To verify this hypothesis, an ROS scavenger, N-
acetylcysteine amide (NACA),47, 48 was used to quench ROS in cell culture. MDA-MB231 
cells were pre-treated with NACA for 30 min prior to the apoptosis induction with SSP (4 
μM) for 2 h. The production of ROS induced by SSP was increased by 2-fold, as compared 
to the untreated control (Figure 5a); while the NACA pretreatment was able to lower ROS 
production to the baseline level. Interestingly, the FITC death signal caused by SSP-induced 
apoptosis was also diminished, as NACA was included in the DL2 labeled MDA-MB231 
cells. Thus suggesting that ROS production could be involved in PDL degradation (Fig. 5b).
ROS are active signaling molecules which direct the cell’s response to stress.49, 50 Under the 
extreme stress condition, such as apoptosis or necrosis, ROS initiate a chain of intracellular 
reactions, resulting in dramatic changes in the dynamic of hydrolysis.45 PDL could be 
hydrolyzed quickly when it was exposed to this stimulated environment. Besides, if PDL 
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and ROS are in close contact, ROS may cause direct chemical fragmentation. It is clear that 
more systematic cellular studies with all types of ROS are required to elucidate the detail 
molecular mechanism of PDL activation.
Discussion
In summary, a chameleon-like multilayered nanoprobe was successfully fabricated by LbL 
deposition. The nanoprobe was taken up efficiently and showed vital fluorescence signal 
immediately in live cells. This PLL fluorescence persisted for long periods of time due to the 
tight coating of the layers and the slow release of the degraded fluorescent signal30. As cells 
began dying, a different fluorescence signal was turned on. The death signal was caused by 
the degradation of PDL, presumably induced by robust ROS production during either the 
apoptotic or necrotic death process. However, the detail mechanism of ROS induced PDL 
degradation remains to be elucidated. The in vivo feasibility study demonstrated the 
potential of studying implanted therapeutic cells in real time. The vital status of cells, 
whether they are live or dead, can be identified clearly by their fluorescence color. This 
study provides a well-defined nanoprobe with the unique property of long-term cell tracking.
Methods
Materials
Poly-L-lysine (Mw = 30,000 ~ 70,000), poly-D-lysine (Mw = 30,000 ~ 70,000), poly acrylic 
acid (35 wt. % solution, average Mw = 15,000), fluorescein 5(6)-isothiocyanate (FITC), 
staurosporine, Annexin V-cy3, ionomycin, and N-acetylcysteine amide (NACA) were 
obtained from Sigma-Aldrich (St. Louis, MO). Bare AuNPs (40 nm) were purchased from 
BB International (Cardiff, UK), Sephadex G-50 was from GE Healthcare Bio-Sciences 
(Pittsburgh, PA), Amicon Ultracel membrane (10 kDa) was from Millipore (Billerica, MA), 
CellTiter aqueous one solution was from Promega (Madison, WI), and DCFDA Cellular 
ROS Detection Assay Kit was from Abcam (Cambridge, MA).
Preparation and validation of PLL-cy5.5
Various amounts of cy5.5 (0.0125, 0.025, 0.05, 0.1, or 0.2 mg) in water (100 μL) were 
reacted with PLL (0.2 mg) in NaHCO3 (1 mM, 100 μL) in the dark at room temperature for 
30 min (vortexed every 10 min). The reaction products were separated using molecular 
weight cutoff membrane filters (10 kDa, Millipore). The resulting PLL-cy5.5 with different 
loads were collected and washed several times with sterilized water until the color of the 
filtrate was clear. The loading ratio of cy5.5 per PLL was calculated based on the absorbance 
of cy5.5. The cy5.5/PLL ratios were from 1/1 (PLL-C1) to 7/1 (PLL-C7) as the amount of 
cy5.5 was increased.
The prepared PLL-cy5.5 (PLL 0.2 nmol in 5 μL) with various loads of cy5.5 were incubated 
with trypsin–ethylenediamine tetraacetic acid (EDTA; 10 μL, 0.25%, Sigma–Aldrich) in 
PBS (185 μL) in a 96-well culture plate at 37 °C. The increase in cy5.5 fluorescence signal 
caused by dequenching was assessed using a plate reader (Tecan, Männedorf, Switzerland) 
with 665 nm excitation and 700 nm emission for 15 h.
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Preparation of PDL-FITC
FITC (0.4 mg) in dimethylformamide (DMF) solution (500 μL) was reacted with PDL (0.2 
mg) in NaHCO3 (1 mM, 500 μL) with constant shaking in the dark at room temperature for 
2 h. The reaction products were separated using molecular weight cutoff membrane filters 
(10 kDa, Millipore). The resulting PDL-FITC was collected and washed several times with 
sterilized water until the color of filtrate was clear. The loading ratio of FITC per PDL was 
6/1, as calculated based on the absorbance of FITC.
Preparation and characterization of multilayered nanoprobe
All nanoprobes were prepared using the same protocol, except the deposition of PLL or PDL 
layers. DL2 is described in detail here. Based on previously developed protocols30, 51, 52, an 
AuNP solution (40 nm, 3.15 × 109 particles in 700 μL) was added dropwise to a PDL-FITC 
solution (PDL, 1.8 nmol in 500 μL). After gentle shaking in the dark for 30 min, the solution 
was centrifuged (30 min at 16,100 g) using a microcentrifuge (Eppendorf, Hauppauge, NY). 
The supernatant was removed, and the gel-like deep red pellet was resuspended in pure 
water and centrifuged again (30 min at 16,100 g). After another wash, PDL-FITC-coated 
AuNPs were re-suspended in pure water (500 μL). Next, the PDL-FITC-coated AuNPs were 
added to a PAA solution (23.3 mM, 500 μL). The reaction solution was incubated in the dark 
for 30 min with gentle shaking, followed by three washes. The deposition procedures were 
repeated with PLL-C6, instead of PDL-FITC, and PAA to have five layers of polyelectrolyte 
(one layer of PDL-FITC, two layers of PLL-cy5.5 and two layers of PAA). Sizes and zeta 
potentials of the prepared nanoparticles in water were measured using Zeta-PALS apparatus 
(Brookhaven, Holtsville, NY) according to the manufacturer’s instructions. D3 and L3 were 
prepared in the same manner but using only PDL-FITC or PLL-C6, respectively.
Protease-assisted fluorescence release from L3
The protease-sensitivity of various PLL-cy5.5 coated AuNPs (three layers) was determined 
by incubating the particles (7.88 × 108 particles) in a 96-well culture plate with or without 
trypsin (25 μL) in PBS at 37 °C. The increase in the cy5.5 fluorescence signal was analyzed 
using a plate reader (Tecan) at 665 nm excitation and 700 nm emission for 24 h.
Cell lines
MDA-MB231 human breast cancer cells and HeLa cells were purchased from ATCC 
(Manassas, VA) and cultured in DMEM medium (Mediatech Inc., Manassas, VA) 
supplemented with 2 mM L-glutamine, 100 U mL−1 penicillin, 100 mg mL−1 streptomycin, 
and 10 % heat-inactivated fetal bovine serum (Sigma-Aldrich). Human mesenchymal stem 
cells (hMSCs) were obtained from Lonza (Walkersville, MD) and cultured in growth 
medium (Mesenchymal Stem Cell Growth Medium Bullet Kit, Lonza). hMSCs between the 
third and fifth passage were used for all experiments. All cells were cultured in a humidified 
atmosphere with 5% CO2 at 37 °C.
Apoptosis imaging with D3 and Annexin V-cy3
MDA-MB231 cells were collected by trypsinization, counted, and plated in a 96-well black 
clear-bottom culture plate (Corning, Pittston, PA) at a density of 1 × 103 cells per well. After 
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1 day, D3 nanoparticles (2.52 × 108 particles) were added and incubated for 12 h. Cells were 
then washed three times with PBS, and cultured in phenol red-free medium. At the indicated 
time points, cells were treated with or without staurosporine (4 μM, 4 h, 37 °C), and then 
stained with Annexin V-cy3 (10 ng) for 15 min at 37 °C. After washing with PBS, cells were 
imaged under a fluorescence microscope (Olympus, Tokyo, Japan).
Quantitation of fluorescent signal changes in cell lysates
MDA-MB231 cells and HeLa cells were seeded in a 6-well culture plate (BD Falcon) at a 
density of 2 × 105 cells per well. One day later, D3 nanoparticles (1.58 × 109 particles) were 
added to each well and cultured for additional 24 h. Cells were treated with staurosporine (4 
μM) for 4 h at 37 °C to induce apoptosis. Cells were harvested, and pelleted cells were lysed 
with 1× lysis buffer (50 mM HEPES, pH 7.4, 5 mM CHAPS, 5 mM DTT), and the lysates 
were transferred to a 96-well black clear-bottom culture plate (Corning) and incubated for 3 
h at 37 °C. The lysates were concentrated using a 10 KDa cut-off membrane (Millipore). 
The increase in the FITC fluorescence signal was assessed for 3 h at 37 °C using a plate 
reader (Tecan) with 480 nm excitation and 530 nm emission.
PDL-FITC degradation by size-exclusion chromatography
Sephadex G-50 (1.3 g) was swollen and equilibrated with 40 mL of PBS buffer for 2 h. 
Columns (1 cm × 30 cm) were packed to a final height of ~ 20 cm and eluted with at least 
one column volume of PBS before the addition of sample. Free PDL-FITC (FITC/PDL = 
6/1, PDL 0.2 nmol in 150 μL) or lysate of D3 labeled and staurosporine treated (4 μM for 4 
h) MDA-MB231 cells was applied to the equilibrated column and eluted at room 
temperature. Fractions were collected in eppendorf tubes after discarding the first 40 drops. 
Each elution tube contained eight drops, and the FITC fluorescence was measured using a 
plate reader (Tecan) with 480 nm excitation and 530 nm emission.
Cell imaging of apoptosis and necrosis with D3 and DL2
MDA-MB231 cells were collected by trypsinization, counted, and plated in a 96-well black 
clear-bottom culture plate (Corning) at a density of 2 × 103 cells per well. hMSCs were 
prepared the same but at a density of 1 × 103 cells per well. After 1 day, D3 or DL2 
nanoprobes (2.52 × 108 particles) were added and incubated for 12 h. Cells were washed 
three times with PBS, cultured in phenol red-free medium, and, at the indicated time points, 
were treated with or without staurosporine (4 μM) or ionomycin (10 μM) for 4 h at 37 °C to 
induce apoptosis or necrosis, respectively. After washing with PBS, cells were imaged under 
a fluorescence microscope (Olympus).
In vivo imaging of DL2 labeled hMSC
After labeling hMSCs with DL2 nanoprobes (9.45 × 108 particles) for 24 h in T-75 flask 
(Sigma-Aldrich), cells were collected and suspended at a concentration of 106 cells/mL. 
Around 10,000 cells (10 μL) were then intradermally injected into the ear pinna of three 
adult C57BL/6 mice (Charles River Laboratories, Wilmington, MA). The FITC and cy5.5 
fluorescence of hMSCs in the ear were imaged using a home built intravital confocal 
scanning microscope35. The studies were in accordance with US National Institutes of 
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Health guidelines for care and use of animals under approval of the Institutional Animal 
Care and Use Committees of Massachusetts General Hospital and Harvard Medical School.
Cytotoxicity assessment of the multilayered nanoprobes
A cell proliferation assay was performed to assess the cytotoxicity of the various treatments. 
Briefly, MDA-MB231 cells, HeLa cells, and hMSCs were collected by trypsinization, 
counted, and plated in a 96-well culture plate at a density of 5 × 103 cells (or 2.5 × 103 of 
hMSCs) per well. One day after seeding, various nanoprobes (2.52 × 108 particles) were 
added and the cells were cultured for additional 24 h. At day 2, 20 μL CellTiter solution 
(Promega) was added to each well and incubated for 3 h. The absorbance of the solution was 
then measured at 490 nm using a plate reader (Tecan).
Measurement of intracellular ROS
The level of intracellular ROS was determined using a DCFDA (2′, 7′-dichlorofluorescein 
diacetate) Cellular ROS Detection Assay Kit (Abcam) according to the manufacturer’s 
instructions. Briefly, MDA-MB231 cells were collected by trypsinization, counted, and 
plated in a 96-well black clear-bottom culture plate (Corning) at a density of 2 × 104 cells 
per well. After 1 day, cells were incubated with DCFDA (20 μM) for 45 min at 37 °C in the 
dark, and then treated with or without 1 mM of NACA for 30 min. SSP (4 μM) in phenol 
red-free medium was added to induce apoptosis for 2 h. The level of ROS was determined 
by measuring the fluorescence intensity using a microplate reader (Tecan) with excitation at 
485 nm and emission at 535 nm.
Fluorescence change according to ROS production
MDA-MB231 cells were collected by trypsinization, counted, and plated in μ-Slide 8-well 
chambered coverslip (ibidi, Martinsried, Germany) at a density of 5 × 103 cells per well. 
After 1 day, DL2 nanoprobes (3.78 × 108 particles) were added and incubated for 12 h. The 
cells were then washed three times with PBS, and cultured in phenol red-free medium with 
or without NACA (1 mM) for 30 min. The cells were treated with SSP (4 μM) and cultured 
for additional 2 h. After washing with PBS, cells were imaged under EVOS FL Auto Cell 
Imaging System (Life technologies, Carlsbad, CA).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Activation of D3 nanoprobes after apoptosis induction in various cells. (a) Schematic 
diagram of D3. (b) MDA-MB231 cells incubated with D3 or Annexin V-cy3 were imaged 
without or (c) with apoptosis induction using staurosporine (SSP, 4 μM) for 4 h. 
Fluorescence signals were assessed using fluorescence microscopy (magnification: 40 ×). 
Scale bar = 100 μm. (d) D3 was incubated with or without apoptosis induction in HeLa and 
MDA-MB231 cells and FITC fluorescence intensity in cell lysates was examined. The 
fluorescence intensity of HeLa cells without treatment was set as 1-fold. Each experiment 
Lee et al. Page 13
Nat Commun. Author manuscript; available in PMC 2016 May 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
was done in triplicate, and the data were shown as mean fluorescence ± SD. (e) Free PDL-
FITC or the collected cell lysate from D3 labeled and SSP treated cells was separated by 
size-exclusion chromatography. The FITC fluorescence intensity of each fraction was 
plotted. Note that the broad fluorescence peak at later time points indicated low molecular 
weight degraded fragments of PDL.
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Figure 2. 
Preparation of cell fate tracker DL2. (a) Schematic illustrating the process of preparing 
multilayered nanoprobes using PDL-FITC/PLL-cy5.5 and PAA as the charged 
polyelectrolytes. Negatively charged PAA layers which are placed between PDL-FITC 
and/or PLL-cy5.5 layers are omitted from the illustration for simplicity. (b) The average size 
(blue bar) and zeta potential (black circle) of each multilayered nanoprobe. All 
measurements were done in triplicate, and the data were shown as mean ± SD.
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Figure 3. 
Live and dead cell imaging with DL2 in MDA-MB231 cells. (a, c) After incubation for 12 h 
with DL2 (or D3), fluorescence signals were assessed by fluorescence microscopy for 4 d. 
(b, d) After 4 d, cells were incubated with staurosporine (SSP, 4 μM) for 4 h to induce 
apoptosis (b) or ionomycin (ION, 10 μM) for 4 h to induce necrosis (d). Fluorescence 
signals mediated by DL2 or D3 were assessed in FITC and cy5.5 channels. Scale bar = 100 
μm.
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Figure 4. 
Live and dead MSC imaging with DL2 in vitro and in vivo. (a) After incubation hMSCs for 
12 h with DL2, fluorescence signals were assessed by fluorescence microscopy for 4 d. 
Scale bar = 100 μm. (b) After 4 d, hMSCs were incubated with 4 μM of staurosporine (SSP) 
for 4 h to induce cell apoptosis. Fluorescence signals mediated by DL2 were assessed in 
each FITC and cy5.5 channels. Scale bar = 100 μm. (c) MSCs labeled with DL2 could be 
visualized in vivo after local injection in the dermis of the mouse ear pinna. MSCs (No. 1 ~ 
7) labeled with DL2 were strongly fluorescent in the cy5.5 channel. A small portion of the 
cells (No. 1 and 2) were co-stained in the FITC channel, indicating that they were 
undergoing cell death. The signal to background ratio was 1.20 and 1.35 for cell 1 and cell 2, 
respectively. Scale bar = 50 μm.
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Figure 5. 
Correlation between ROS production and cell death signal. (a) DCF fluorescence intensity 
was measured after treating MDA-MB231 cells with SSP (4 μM) for 2 h in the presence or 
absence of NACA (1 mM). The fluorescence intensity of the untreated MDA-MB231 cells 
was set as 100%. Each experiment was performed at least three times, and the results were 
expressed as the median change in fluorescence ± SD. (b) Fluorescence images of DL2 
incubated MDA-MB231 cells after apoptosis induction with SSP (4 μM, 2 h) in the presence 
or absence of NACA (1 mM). The FITC signal was significantly reduced in the NACA 
treated cells. Scale bar = 100 μm.
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